The onset of an MH crisis demands swift and decisive action. Key steps in its management encompass the rapid identification of the crisis, immediate cessation of the triggering agents, the application of charcoal filters in the anesthesia circuit, and crucially, the administration of dantrolene, the recognized antidote for MH.
Simultaneously, the surgical team should be promptly notified and the ongoing procedure halted, if feasible. Emphasis should be on optimizing oxygenation and ventilation, with the goal being a reduction in ETCO2 and elevating inspired oxygen to 100%. To assist clinicians during these critical moments, several cognitive aids have been developed, including guidelines by MHAUS and resources like the Stanford Emergency Manual. Furthermore, hotlines staffed by board-certified anesthesiologists experienced in managing MH offer round-the-clock assistance.
Timeliness in dantrolene administration is paramount. The quicker it's introduced into the patient's system, the better the potential outcomes. While immediate administration is ideal, practical constraints, especially related to the reconstitution of dantrolene, can pose challenges. During such times, enlisting additional clinical hands can expedite the process.
